characteristics.text: SAMN33411800
characteristics.characteristic: External Id
characteristics.text: Biomedical Engineering, Columbia University
characteristics.characteristic: INSDC center name
characteristics.text: 2023-03-11T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-03-11T01:16:30.927Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16861509
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16861509
characteristics.characteristic: SRA accession
characteristics.text: A172 cells
characteristics.characteristic: cell line
characteristics.text: Human glioblastoma brain cancer cells expressing dCas9-KRAB or dCas9-SunTag and further transduced to express single-guide RNAs against HPRT1, mismatch repair genes or non-targeting control single-guide RNAs.
characteristics.characteristic: cell type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: A172 cells
characteristics.characteristic: source_name
characteristics.text: sciPlexGxE_1
characteristics.characteristic: title
characteristics.text: Cells were treated with increasing doses of 6-thioguanine, Temozolomide or dmso vehicle control.
characteristics.characteristic: treatment